You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
塞力斯(603716.SH)子公司獲醫療器械註冊證書
格隆匯 12-30 22:51

格隆匯12月30日丨塞力斯(603716.SH)公佈,公司全資子公司武漢塞力斯生物技術有限公司於近日收到湖北省藥品監督管理局頒發的《中華人民共和國醫療器械註冊證(體外診斷試劑)》。

抗核抗體(ANA)譜檢測試劑盒(免疫印跡法)採用免疫印跡法,用於體外定性檢測人血清中抗RNP/Sm、Sm、SSA/Ro-60、Ro-52、SSB/La、DNA拓撲異構酶I(Scl-70)、PM/Scl、組氨酰-tRNA合成酶(Jo-1)、着絲點B(CENP-B)、PCNA、雙鏈DNA(dsDNA)、核小體(Nuclesome)、組蛋白(Histone)、核糖體P蛋白(P0)、AMA-M2的IgG類抗體。目前同類型產品,外資品牌銷售佔比較高。公司累計對該項目的研發投入約為人民幣200萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account